Table of Contents
ISRN Neurology
Volume 2014, Article ID 167030, 4 pages
http://dx.doi.org/10.1155/2014/167030
Research Article

Urinary Catheterization May Not Adversely Impact Quality of Life in Multiple Sclerosis Patients

1Department of Urology, Division of Female Pelvic Medicine and Reconstructive Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, LKSD 5046, Cleveland, OH 44106, USA
2University Hospitals Case Medical Center, 11100 Euclid Avenue, MAC 5034, Cleveland, OH 44106, USA
3Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, MAC 5034, Cleveland, OH 44106, USA

Received 5 December 2013; Accepted 29 December 2013; Published 20 February 2014

Academic Editors: M. G. Grasso, A. Karni, and T. Müller

Copyright © 2014 Rebecca James et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background. Multiple sclerosis (MS) healthcare providers (HCP) have undergone considerable educational efforts regarding the importance of evaluating and treating pelvic floor disorders, specifically, urinary dysfunction. However, limited data are available to determine the impact of catheterization on patient quality of life (QoL). Objectives. To describe the use of urinary catheterization among MS patients and determine the differences between those who report positive versus negative impact of this treatment on QoL. Methods. Patients were queried as part of the 2010 North American Research Committee On Multiple Sclerosis survey; topics included 1) urinary/bladder, bowel, or sexual problems; 2) current urine leakage; 3) current catheter use; 4) catheterizing and QoL. Results. Respondents with current urine leakage were 5143 (54.7%), of which 1201 reported current catheter use (12.8%). The types of catheters (intermittent self-catheterization and Foley catheter (indwelling and suprapubic)) did not differ significantly. Of the current catheter users, 304 (25.35%) respondents reported catheterization negatively impacting QoL, 629 (52.4%) reported a positive impact on QoL, and 223 (18.6%) reported neutral QoL. Conclusions. A large proportion of catheterized MS patients report negative or positive changes in QoL associated with urinary catheterization. Urinary catheterization does not appear to have a universally negative impact on patient QoL.